Hong Kong Island, Hong Kong, China The standard case for the fund is to invest in rounds with more than 10 partakers. Despite the Viva Ventures Biotech Group, startups are often financed by Quark Venture, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Total Access Fund, Strawberry Creek Ventures, Polaris Partners.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight SQZ Biotech. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018.
Funds with similar focus
| Fund Name | Location |
| Block Ventures | California, Los Angeles, United States |
| Cahc co., Ltd. | Aichi Prefecture, Japan, Nagoya |
| DQE Enterprises | Pennsylvania, Pittsburgh, United States |
| IDI | France, Ile-de-France, Paris |
| Lanse Caihong Keji | China, Guangdong, Shenzhen |
| Maytag Corporation | Benton Harbor, Michigan, United States |
| Plus Eight Equity Fund LP | New York, New York, United States |
| Zimmer Lucas Partners | New York, New York, United States |
| zulily | Seattle, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Arthrosi Therapeutics | $14M | 22 Oct 2021 | California, United States | ||
Basking Biosciences | 18 Aug 2021 | Durham, North Carolina, United States | |||
Riparian Pharmaceuticals | 01 Apr 2021 | Boston, Massachusetts, United States | |||
Blue Oak Pharmaceuticals | $9M | 01 Feb 2021 | Waltham, Massachusetts, United States | ||
Sisu Pharma | $1M | 19 Oct 2020 | Chapel Hill, North Carolina, United States | ||
Anji Pharmaceuticals | $12M | 01 Jul 2020 | Cambridge, Massachusetts, United States | ||
Proviva Therapeutics, Inc | 02 Jan 2020 | - | |||
VivaVision Biotech | $10M | 26 Sep 2019 | Shanghai, China | ||
Anji Pharmaceuticals | $14M | 28 Jun 2019 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Arthrosi Therapeutics | $14M | 22 Oct 2021 | California, United States | ||
Basking Biosciences | 18 Aug 2021 | Durham, North Carolina, United States | |||
Riparian Pharmaceuticals | 01 Apr 2021 | Boston, Massachusetts, United States | |||
Blue Oak Pharmaceuticals | $9M | 01 Feb 2021 | Waltham, Massachusetts, United States | ||
Sisu Pharma | $1M | 19 Oct 2020 | Chapel Hill, North Carolina, United States | ||
Anji Pharmaceuticals | $12M | 01 Jul 2020 | Cambridge, Massachusetts, United States | ||
Proviva Therapeutics, Inc | 02 Jan 2020 | - | |||
VivaVision Biotech | $10M | 26 Sep 2019 | Shanghai, China | ||
Anji Pharmaceuticals | $14M | 28 Jun 2019 | Cambridge, Massachusetts, United States |
